Interestingly, when the potential therapeutic target for psoriasis and psoriatic arthritis (PsA) was analyzed via priority index calculation (based on GWAS), CCL11 was identified as a target for PsA therapy [11]. The gene discussed is CCL11; the disease is psoriasis.